GPCR STRUCTURE THERAPEUTICS INC
2026Q2 · CUSIP 86366E106 · Sector: Healthcare & Biotech
Fund flows are within the usual range
190 funds held GPCR at the end of 2026Q2, down 3 from the quarter before. Fund flows are within the usual range — nothing unusual. GPCR has had 5 buying rushes in its history, and the price moved +28.3% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.
How many funds owned it, quarter by quarter
Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.
What happened after each past buying rush 5 times in its history
| Quarter of the rush | How unusual then | Price, next 3 months | Price, next 6 months |
|---|---|---|---|
| 2025Q4 | Top 20% | -45.4% | -27.2% |
| 2025Q2 | Top 20% | +84.5% | +242.5% |
| 2024Q2 | Top 5% | +1.5% | -35.7% |
| 2023Q4 | Top 20% | -21.1% | -12.4% |
| 2023Q3 | Top 5% | -9.6% | -25.4% |
These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.
Show all the numbers (large funds, value held, options…) ▾ Collapse ▴
These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.
Email me the next update
2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.